|
Name of Journal:
World Journal of Hematology
|
|
Position:
Editorial Board
|
|
Status:
Accepted
|
|
Regist Date:
September 06, 2023
|
|
Accepted:
February 06, 2025
|
|
Research Domain:
Research & Experimental Medicine
|
|
Peer-Review Count:
0
|
|
Invited Times:
134
|
|
Review Rate:
0.0%
|
|
Editorial Triage Count:
0
|
|
Second Decision Count:
0
|
|
Last Invited:
June 11, 2025
|
|
Last Declined:
June 11, 2025
|
|
Articles Published in Baishideng Series Journals:
0
|
|
Research Keywords: CD133; CD34; Cell Cycle Regulation; Hematopoietic Progenitor Cells; Hematopoietic Stem Cells; Molecular Mechanisms Of Leukemogenesis; Normal Hematopoiesis; Oncogenes; Signal Transduction; Transcription Factors
|
Biography: Dr. Edgar Grinstein is Editor-In-Chief of the Signal Transduction Insights Journal published by SAGE Publications Inc. (United States ) and a Principal Investigator at the Heinrich Heine University in Düsseldorf ... [+]
Biography: Dr. Edgar Grinstein is Editor-In-Chief of the Signal Transduction Insights Journal published by SAGE Publications Inc. (United States ) and a Principal Investigator at the Heinrich Heine University in Düsseldorf (Germany). He researches signal transduction, gene transcription regulation, hematopoietic stem cells and progenitor cells. Raised in a family of researchers – both parents are PhD scientists - Grinstein received his PhD summa cum laude in Molecular Biology from the Humboldt University and the Max-Delbrück Center for Molecular Medicine in Berlin. He has published a number of papers in high-ranking journals and received a highly regarded Research Award from Dr.-Günther- and Imme-Wille-Foundation. He is on Editorial Board of Frontiers in Bioscience. Dr. Grinstein qualified as Professor in Molecular Medicine at the University of Düsseldorf in 2008 and is appointed a Visiting Professor at the University of Latvia (Latvia, European Union) since 2010. Dr. Grinstein`s research in the field of hematopoietic stem and progenitor cells, funded by individual research grants from German Research Foundation (DFG) and José Carreras Leukämie-Stiftung (José Carreras Foundation), has focused on markers, signal transduction and transcriptional control. In a recently published study (Leukemia 2015; 29: 2208-2220), Dr. Grinstein`s research group investigated the role of prominent surface marker AC133/CD133, that is expressed on stem/progenitor cells in normal hematopoiesis as well as on tumor-initiating cells in certain hematological malignancies. The study dissected control of AC133/CD133 expression in hematopoietic stem/progenitor cells, and revealed the impact thereof on molecular network relevant to these cells. Dr. Grinstein can be contacted at Edgar. [-]
|
|
Total View:
477 (4/20)
|
|
Total Articles:
23 (18/20)
|
|
Total Citations in RCA:
1009 (12/20)
|
|
First Author Articles:
10 (16/20)
|
|
First Author Article Citations:
269 (13/20)
|
|
Corresponding Author Articles:
2 (16/20)
|
|
Corresponding Author Article Citations:
0
|
|
Author Article Influence Index:
48.348 (mean) (1/20)
|
|
Institution URL:
https://www.hhu.de/en/
|
|
Institution:
Edgar Grinstein, PhD, Professor, Department of Hematology, Oncology and Clinical Immunology, Heinrich Heine University, Düsseldorf D-40225, Germany
|